These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 8740329

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease.
    Riccio A, Del Puente A, Farinaro C, Scarpa R, Oriente P, Rocco P, Gioia M.
    Clin Ther; 1987; 9(2):232-7. PubMed ID: 3568066
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M, Cobankara V, Akpolat T.
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [Abstract] [Full Text] [Related]

  • 5. Serotonin reuptake inhibitors, Raynaud's phenomenon and erythromelalgia.
    Rey J, Cretel E, Jean R, Pastor MJ, Durand JM.
    Rheumatology (Oxford); 2003 Apr; 42(4):601-2. PubMed ID: 12649412
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nifedipine and alpha 1-adrenergic blockade in Raynaud's phenomenon.
    Kahan A, Foult JM, Weber S, Amor B, Menkes CJ, Degeorges M.
    Eur Heart J; 1985 Aug; 6(8):702-5. PubMed ID: 4054140
    [Abstract] [Full Text] [Related]

  • 9. Effects of low-dose nifedipine on a cold provocation test in patients with Raynaud's disease.
    Weber A, Bounameaux H.
    J Cardiovasc Pharmacol; 1990 May; 15(5):853-5. PubMed ID: 1692948
    [Abstract] [Full Text] [Related]

  • 10. Functional vascular diseases: Raynaud's syndrome, acrocyanosis and erythromelalgia.
    Heidrich H.
    Vasa; 2010 Feb; 39(1):33-41. PubMed ID: 20186674
    [Abstract] [Full Text] [Related]

  • 11. Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effects.
    Kallenberg CG, Wouda AA, Kuitert JJ, Tijssen J, Wesseling H.
    J Rheumatol; 1987 Apr; 14(2):284-90. PubMed ID: 3598997
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of Raynaud's syndrome with calcium entry blockers].
    Shcherbakov AB, Guseva NG, Mach ES.
    Ter Arkh; 1987 Apr; 59(4):89-92. PubMed ID: 3296288
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vibrotactile sensation and response to nifedipine dose titration in primary Raynaud's phenomenon.
    Challenor VF, Waller DG, Hayward RA, Griffin MJ, Roath OS.
    Angiology; 1989 Feb; 40(2):122-8. PubMed ID: 2644877
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nifedipine and Raynaud's phenomenon associated with connective tissue diseases.
    Kahan A, Weber S, Amor B, Menkes CJ, Hodara M, Degeorges M.
    Int Angiol; 1985 Feb; 4(2):221-3. PubMed ID: 3831143
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.